Outcome of Secondary Stroke Prevention in Patients Taking Non–Vitamin K Antagonist Oral Anticoagulants


Since non–vitamin K antagonist oral anticoagulants (NOACs) were released for clinical use, many studies have investigated its effectiveness in stroke prevention. In this study, to determine whether or not there is a difference in outcome in secondary stroke prevention between warfarin and NOACs, patients with embolic stroke with newly prescribed anticoagulants were prospectively analyzed.


Leave A Reply